Insider · CIK 0001008227
Steven C Quay
Files at ATOS (ATOSSA THERAPEUTICS, INC.). First filing May 22, 2025, latest May 22, 2025.
Steven C Quay files SEC Form 4 as CEO, president and director at ATOS (ATOSSA THERAPEUTICS, INC.). Since May 22, 2025, Steven C Quay has reported 1 open-market buy worth $9,887 and 0 open-market sells worth $0, the latest filed on May 22, 2025.
A track record needs three past buys with six months of prices behind them; Steven C Quay has 0, so none is measured yet.
The newest scored trade: bought $9,887 of ATOS on May 21, 2025, filed May 22, 2025, scored 43 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ATOS: ATOSSA THERAPEUTICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | ATOSbuy ATOSSA THERAPEUTICS, INC. | $9,887 11,239 shares | +423% | +47% from low-46% from high |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | ATOS ATOSSA THERAPEUTICS, INC. | AGrant or award Common Stock | +65,000 | $0.00 | $0 | 88,038 | Mar 31, 2026 |
| Jan 20, 2026 | ATOS ATOSSA THERAPEUTICS, INC. | AGrant or award Common Stock | +331,674 | $0.00 | $0 | 345,572 | Jan 30, 2026 |
| Jan 20, 2026 | ATOS ATOSSA THERAPEUTICS, INC. | AGrant or award Stock Options (right to buy)derivative | +950,000 | $0.60 | $573k | 950,000 | Jan 30, 2026 |
| Jan 20, 2026 | ATOS ATOSSA THERAPEUTICS, INC. | AGrant or award Common Stock | +325,203 | $0.00 | $0 | 339,101 | Jan 22, 2026 |
| Jan 20, 2026 | ATOS ATOSSA THERAPEUTICS, INC. | AGrant or award Stock Options (right to buy)derivative | +950,000 | $0.60 | $573k | 950,000 | Jan 22, 2026 |
| May 21, 2025 | ATOS ATOSSA THERAPEUTICS, INC. | POpen-market purchase Common Stock | +11,239 | $0.88 | $9,887 | 13,898 | May 22, 2025 |
| May 15, 2025 | ATOS ATOSSA THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +1,366,062 | $0.00 | $0 | 1,366,062 | May 16, 2025 |
Questions about Steven C Quay
Answered from the filings on this page, as of the latest one.
Is Steven C Quay buying or selling?
Not in the last 12 months. Steven C Quay's latest open-market trade on SEC Form 4 was bought $9,887 of ATOS on May 21, 2025.
How did Steven C Quay's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Steven C Quay has 0.
Where does Steven C Quay file Form 4?
Steven C Quay has filed Form 4 at ATOS (ATOSSA THERAPEUTICS, INC.) as President & CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.